Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7d684dbfc8-hffkp Total loading time: 0 Render date: 2023-09-26T10:36:31.141Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "coreDisableSocialShare": false, "coreDisableEcommerceForArticlePurchase": false, "coreDisableEcommerceForBookPurchase": false, "coreDisableEcommerceForElementPurchase": false, "coreUseNewShare": true, "useRatesEcommerce": true } hasContentIssue false

Section 4 - Antenatal Care: Specific Maternal Conditions

Published online by Cambridge University Press:  05 March 2016

Edited by
Philip J. Steer  and
Michael A. Gatzoulis
Philip J. Steer
Affiliation:
Chelsea and Westminster Hospital, London
Michael A. Gatzoulis
Affiliation:
Royal Brompton Hospital, London
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Heart Disease and Pregnancy , pp. 106 - 207
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Yun, KL, Miller, DC, Moore, KA, et al. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg 1995;60(2 Suppl):S221–8.CrossRefGoogle ScholarPubMed
Jamieson, WR, Janusz, MT, Miyagishima, RT, et al. The Carpentier–Edwards standard porcine bioprosthesis: Long-term evaluation of the high pressure glutaraldehyde fixed prosthesis. J Card Surg 1988;3(3 Suppl):321–36.CrossRefGoogle ScholarPubMed
Badduke, BR, Jamieson, WR, Miyagishima, RT, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991;102:179–86.Google Scholar
Avila, WS, Rossi, EG, Grinberg, M, et al. Influence of pregnancy after bioprosthetic valve replacement in young women: A prospective five year study. J Heart Valve Dis 2002;11:864–9.Google ScholarPubMed
Jamieson, WR, Miller, DC, Akins, CW, et al. Pregnancy and bioprostheses: Influence on structural valve deterioration. Ann Thorac Surg 1995;60 (2 Suppl):S282–6; discussion S287.CrossRefGoogle ScholarPubMed
North, RA, Sadler, L, Stewart, AW, et al. Long term survival and valve related complications in young women with cardiac valve replacements. Circulation 1999;99:2669–76.CrossRefGoogle ScholarPubMed
McClintock, C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: No easy option. Thromb Res 2011;127 (Suppl 3):S56–60.CrossRefGoogle Scholar
Elkayam, U, Singh, H, Irani, A, et al. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107–15.CrossRefGoogle ScholarPubMed
Dahlman, TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993;168:1265–70.CrossRefGoogle ScholarPubMed
Decousus, HA, Croze, M, Levi, FA, et al. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J (Clin Res Ed) 1985;290:341–4.CrossRefGoogle Scholar
Chunilal, SD, Young, E, Johnston, MA, et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002;87:92–7.Google ScholarPubMed
Brill-Edwards, PA, Demers, C, Donovan, D, et al. Establishing a therapeutic range for heparin therapy. Chest 1993;104:1679–84.Google Scholar
Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438–88.Google Scholar
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Chan, WS, Anand, S, Ginsberg, JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000;160:191–6.CrossRefGoogle ScholarPubMed
Meschengieser, SS, Fondevila, CG, Santarelli, MT, et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23–6.CrossRefGoogle ScholarPubMed
Hall, JG, Pauli, RM, Wilson, KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122–40.CrossRefGoogle ScholarPubMed
Ginsberg, JS, Hirsh, J, Turner, DC, et al. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989;61:197–203.Google ScholarPubMed
Hung, L, Rahimtoola, SH. Prosthetic valves and pregnancy. Circulation 2003;107:1420–6.CrossRefGoogle Scholar
Cotrufo, M, de Luca, TS, Calabro, R, et al. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 1991;5:300–4; discussion 305.CrossRefGoogle ScholarPubMed
Vitale, N, De Feo, M, De Santo, LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637–41.CrossRefGoogle ScholarPubMed
Mazibuko, B, Ramnarain, H, Moodley, J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: A five-year experience. Cardiovasc J Afr 2012;23:216–21.CrossRefGoogle Scholar
Sillesen, M, Hjortdal, V, Vejlstrup, N, et al. Pregnancy with prosthetic heart valves—30 years’ nationwide experience in Denmark. Eur J Cardiothorac Surg 2011;40:448–54.Google ScholarPubMed
Wesseling, J, Van Driel, D, Heymans, HS, et al. Coumarins during pregnancy: Long-term effects on growth and development of school-age children. Thromb Haemost 2001;85:609–13.Google ScholarPubMed
McClintock, C. Anticoagulant choices in pregnant women with mechanical heart valves: Balancing maternal and fetal risks—the difference the dose makes. Thromb Res 2013;131 (Suppl 1):S8–10.CrossRefGoogle Scholar
Soma-Pillay, P, Nene, Z, Mathiva, TM, et al. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstset Medicine 2011;4:24–27.CrossRefGoogle ScholarPubMed
Basude, S, Hein, C, Curtis, SL, et al. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: What are the risks? A retrospective observational study. BJOG 2012;119:1008–13; discussion 12–13.CrossRefGoogle ScholarPubMed
Thorp, JA, Poskin, MF, McKenzie, DR, et al. Perinatal factors predicting severe intracranial hemorrhage. Am J Perinatol 1997;14:631–6.CrossRefGoogle ScholarPubMed
White, RH, Ginsberg, JS. Low-molecular-weight heparins: Are they all the same? Br J Haematol 2003;121:12–20.CrossRefGoogle ScholarPubMed
Rowan, JA, McCowan, LM, Raudkivi, PJ, et al. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:633–7.CrossRefGoogle ScholarPubMed
McClintock, C, McCowan, LM, North, RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 2009;116:1585–92.CrossRefGoogle Scholar
Abildgaard, U, Sandset, PM, Hammerstrom, J, et al. Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with low molecular weight heparin. Thromb Res 2009;124:262–7.CrossRefGoogle ScholarPubMed
Mahesh, B, Evans, S, Bryan, AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002;11:745–50.Google Scholar
Yinon, Y, Siu, SC, Warshafsky, C, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol 2009;104:1259–63.CrossRefGoogle ScholarPubMed
Oran, B, Lee-Parritz, A, Ansell, J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004;92:747–51.Google ScholarPubMed
Saeed, CR, Frank, JB, Pravin, M, et al. A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves. Clin Appl Thromb Hemost 2011;17:313–19.Google ScholarPubMed
Quinn, J, Von Klemperer, K, Brooks, R, et al. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: A single-center experience. Haematologica 2009;94:1608–12.CrossRefGoogle ScholarPubMed
Sephton, V, Farquharson, RG, Topping, J, et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003;101:1307–11.Google ScholarPubMed
Casele, HL, Laifer, SA, Woelkers, DA, et al. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999;181(5 Pt 1):1113–17.CrossRefGoogle ScholarPubMed
Barbour, LA, Oja, JL, Schultz, LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 2004;191:1024–9.CrossRefGoogle ScholarPubMed
Ginsberg, JS, Chan, WS, Bates, SM, et al. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694–8.CrossRefGoogle ScholarPubMed
Cappelleri, JC, Fiore, LD, Brophy, MT, et al. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A meta analysis. Am Heart J 1995;130 (3 Pt 1):547–52.CrossRefGoogle Scholar
Imperiale, TF, Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266:260–4.Google ScholarPubMed

References

Huisman, CM, Zwart, JJ, Roos-Hesselink, JW et al. Incidence and predictors of maternal cardiovascular mortality and severe morbidity in the Netherlands: A prospective cohort study. PLoS ONE 2013;8:e56494.CrossRefGoogle ScholarPubMed
Cantwell, R, Clutton-Brock, T, Cooper, G. Saving Mothers’ Lives. Reviewing maternal death to make motherhood safer 2006–2008. BJOG 2011;118(Supp.1):1–203.Google ScholarPubMed
Mabie, WC, DiSessa, TG, Crocker, LG, et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 1994;170:849–56.CrossRefGoogle ScholarPubMed
Robson, SC, Hunter, S, Boys, RJ. et al. Serial study of factors influencing changes in cardiac output during pregnancy. Am J Physiol 1989;256:H1060–5.Google ScholarPubMed
Poppas, A, Shroff, SG, Korcarz, CE et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation 1997;95:2407–15.CrossRefGoogle ScholarPubMed
Gutin, LS, Merz, AE, Bakalov, VK et al. Parity and aortic dimensions in healthy women. Int J Cardiol 2013;165(2):383–4.CrossRefGoogle ScholarPubMed
Campisi, D, Cutolo, M, Carruba, G et al. Evidence for soluble and nuclear site I binding of estrogens in human aorta. Atherosclerosis 1993;103:267–77.CrossRefGoogle ScholarPubMed
Wingrove, CS, Garr, E, Godsland, IF et al. 17-beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998;1406:169–74.Google ScholarPubMed
Manallo-Estrella, P, Barker, AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Path 1967;83:336–41.Google Scholar
Pedowitz, P, Perell, A. Aneurysms complicated by pregnancy. I. Aneurysms of the aorta and its major branches. Am J Obstet Gynecol 1957;73(4):720–35.CrossRefGoogle ScholarPubMed
Pyeritz, RE. Disorders of fibrillins and microfibrilogenesis: Marfan syndrome, MASS phenotype, contractural arachnodactyly and related conditions. In: Principles and Practice of Medical Genetics, 3rd edn. New York: Churchill Livingstone; 1996.Google Scholar
Lind, J, Wallenburg, HC. The Marfan syndrome and pregnancy: A retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 2001;98(1):28–35.CrossRefGoogle Scholar
Meijboom, LJ, Drenthen, W, Pieper, PG et al. Obstetric complications in Marfan syndrome. Int J Cardiol 2006;110:53–9.CrossRefGoogle ScholarPubMed
Pini, R, Roman, MJ, Kramer-Fox, R et al. Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects. Circulation 1989;80:915–24.CrossRefGoogle ScholarPubMed
Schnitker, MA, Bayer, CA. Dissection aneurysm of the aorta in young individuals, particularly in association with pregnancy. Ann Intern Med 1944;29:486–511.Google Scholar
Williams, GM, Gott, VL, Brawley, RK. et al. Aortic disease associated with pregnancy. J Vasc Surg 1988;8:470–5.CrossRefGoogle ScholarPubMed
Hirst, AE, Johns, VJ, Kime, SW. Dissecting aneurysm of the aorta: A review of 505 cases. Medicine (Baltimore) 1958;37:217–79.CrossRefGoogle ScholarPubMed
Oskoui, R, Lindsay, J. Aortic dissection in women < 40 years of age and the unimportance of pregnancy. Am J Cardiol 1994;73(11):821–3.CrossRefGoogle ScholarPubMed
Meijboom, LJ, Vos, FE, Timmermans, J et al. Pregnancy and aortic root growth in the Marfan syndrome: A prospective study. Eur Heart J 2005:26(9):914–20.CrossRefGoogle ScholarPubMed
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Hiratzka, LF, Bakris, GL, Beckman, JA et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 2010;55(14):e27–e129.
Groenink, M, Lohuis, TAJ, Tijssen, JGP et al. Survival and complication free survival in Marfan syndrome: Implications of current guidelines. Heart 1999;82:499–504.CrossRefGoogle ScholarPubMed
Silverman, DI, Gray, J, Roman, MJ et al. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol 1995;26(4):1062–7.CrossRefGoogle ScholarPubMed
Immer, FF, Bansi, AG, Immer-Bansi, AS. et al. Aortic dissection in pregnancy: Analysis of risk factors and outcome. Ann Thorac Surg 2003;76(1):309–14.CrossRefGoogle ScholarPubMed
Williams, A, Child, A, Rowntree, J et al. Marfan syndrome: Successful pregnancy after aortic root and arch replacement. BJOG 2002;109(10):1187–8.CrossRefGoogle ScholarPubMed
Shores, J, Berger, KR, Murphy, EA et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan syndrome. N Engl J Med 1994;330(19):1335–41.CrossRefGoogle Scholar
Groenink, M, de Roos, A, Mulder, BJ et al.Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 1998;82(2):203–8.CrossRefGoogle ScholarPubMed
Gao, L, Mao, Q, Wen, D et al. The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan syndrome: A meta-analysis. Acta Paediatr 2011;100(9):e101–5.CrossRefGoogle ScholarPubMed
Groenink, M, den Hartog, AW, Franken, R et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: A randomized controlled trial. Eur Heart J 2013;34(45):3491–500.CrossRefGoogle ScholarPubMed
Harton, GL, Tsipouras, P, Sisson, ME. et al. Preimplantation genetic testing for Marfan syndrome. Mol Hum Reprod 1996;2(9):713–5.CrossRefGoogle ScholarPubMed
Regalado, ES, Guo, DC, Estrera, AL et al. Acute aortic dissections with pregnancy in women with ACTA2 mutations. Am J Med Genet A 2014;164:106–12.CrossRefGoogle Scholar
Rossiter, JP, Repke, JT, Morales, AJ et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995;173(5):1599–606.CrossRefGoogle ScholarPubMed
Zeebregts, CJ, Schepens, MA, Hameeteman, TM et al. Acute aortic dissection complicating pregnancy. Ann Thorac Surg 1997;64:1345–8.CrossRefGoogle ScholarPubMed
Parry, AJ, Westaby, S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996;61(6):1865–9.CrossRefGoogle ScholarPubMed
Mahli, A, Izdes, S, Coskun, D. Cardiac operations during pregnancy: Review of factors influencing fetal outcome. Ann Thorac Surg 2000;69:1622–6.CrossRefGoogle ScholarPubMed
Lacassie, HJ, Millar, S, Leithe, LG et al. Dural ectasia: A likely cause of inadequate spinal anaesthesia in two parturients with Marfan syndrome. Br J Anaesth 2005;94(4):500–4.CrossRefGoogle Scholar
Beauchesne, LM, Connolly, HM, Ammash, NM et al. Coarctation of the aorta: Outcome of pregnancy. J Am Coll Cardiol 2001;38(6):1728–33.CrossRefGoogle ScholarPubMed
Stern, HC, Locher, D, Wallnofer, K et al. Noninvasive assessment of coarctation of the aorta: Comparative measurements by two-dimensional echocardiography, magnetic resonance, and angiography. Pediatr Cardiol 1991;12(1):1–5.CrossRefGoogle ScholarPubMed
Stewart, AB, Ahmed, R, Travill, CM et al. Coarctation of the aorta life and health 20–44 years after surgical repair. Br Heart J 1993;69(1):65–70.CrossRefGoogle Scholar
Siu, SC, Sermer, M, Colman, JM et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104(5):515–21.CrossRefGoogle ScholarPubMed
Kupferminc, MJ, Lessing, JB, Jaffa, A et al. Fetomaternal blood flow measurements and management of combined coarctation and aneurysm of the thoracic aorta in pregnancy. Acta Obstet Gynecol Scand 1993;72(5):398–402.CrossRefGoogle ScholarPubMed
Knyshov, GV, Sitar, LL, Glagola, MD et al. Aortic aneurysms at the site of the repair of coarctation of the aorta: A review of 48 patients. Ann Thorac Surg 1996;61(3):935–9.CrossRefGoogle ScholarPubMed
Rose, V, Gold, RJM, Lindsay, G et al. A possible increase in the incidence of congenital heart defects among the offspring of affected parents. JACC 1985;6:376–82.CrossRefGoogle ScholarPubMed
Cecconi, M, Manfrin, M, Moraca, A et al. Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol 2005;95(2):292–4.CrossRefGoogle ScholarPubMed
Oliver, JM, Alonso-Gonzalez, R, Gonzalez, AE et al. Risk of aortic root or ascending aorta complications in patients with bicuspid aortic valve with and without coarctation of the aorta. Am J Cardiol 2009;104(7):1001–6.CrossRefGoogle ScholarPubMed
McKellar, SH, MacDonald, RJ, Michelena, HI et al. Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. Am J Cardiol 2011;107:96–9.CrossRefGoogle Scholar
Ostberg, JE, Brookes, JA, McCarthy, C et al. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89(12):5966–71.CrossRefGoogle ScholarPubMed
Hagman, A, Loft, A, Wennerholm, UB et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: A Nordic cohort study. Hum Reprod 2013;28(6):1598–609.CrossRefGoogle ScholarPubMed
Lurie, S, Manor, M, Hagay, ZJ. The threat of type IV Ehlers-Danlos syndrome on maternal well-being during pregnancy: Early delivery may make the difference. J Obstet Gynaecol 1998;18(3):245–8.Google ScholarPubMed
Hauenstein, E, Frank, H, Bauer, JS. et al. Takayasu’s arteritis in pregnancy: Review of literature and discussion. J Perinat Med 2010;38:55–62.CrossRefGoogle ScholarPubMed

References

Haththotuwa, HR, Attygalle, D, Jayatilleka, AC, et al. Maternal mortality due to cardiac disease in Sri Lanka. Int J Gynecol Obstet 2009;104 :194–8.CrossRefGoogle ScholarPubMed
Naidoo, DP, Desai, DK, Moodley, J. Maternal deaths due to pre-existing cardiac disease. Cardiovasc J South Afr 2002;13 :17–20.Google ScholarPubMed
Lewis, G, ed. Why Mothers Die 2000–2002: The Sixth Report of Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004.Google Scholar
Silversides, CK, Colman, JM, Sermer, M, et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003;91:1382–5.CrossRefGoogle ScholarPubMed
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Nercolini, DC, da Rocha Loures Bueno, R, Eduardo Guerios, E, et al. Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis. Catheter Cardiovasc Interv 2002;57:318–22.CrossRefGoogle ScholarPubMed
Routray, SN, Mishra, TK, Swain, S, et al. Balloon mitral valvuloplasty during pregnancy. Int J Gynaecol Obstet 2004;85:18–23.CrossRefGoogle ScholarPubMed
Gupta, A, Lokhandwala, YY, Satoskar, PR, et al. Balloon mitral valvotomy in pregnancy: Maternal and fetal outcomes. J Am Coll Cardiol 1998;187:409–15.Google ScholarPubMed
Sivadasanpillai, H, Srinivasan, A, Sivasubramoniam, S, et al. Long term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol 2005;95:1504–6.CrossRefGoogle ScholarPubMed
Aggarwal, N, Suri, V, Goyal, A, et al. Closed mitral valvotomy in pregnancy and labour. Int J Gynecol Obstet;2005:118–21.CrossRefGoogle Scholar
Hameed, A, Karaalp, IS, Tummala, PP, et al. The effects of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893–9.CrossRefGoogle ScholarPubMed
Aria, F, Pineda, J. Aortic stenosis and pregnancy. J Reprod Med 1978;20:229–32.Google Scholar
Silversides, C, Colman, J, Sermer, M, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol 2003;91:1386–9.CrossRefGoogle ScholarPubMed
Tzemos, N, Silversides, CK, Colman, JM, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J 2009;157 :474–80.CrossRefGoogle ScholarPubMed
Magne, J, Lancellotti, P, Pierard, LA. Exercise testing in asymptomatic severe aortic stenosis. J Am Coll Cardol Cardiovasc Imaging 2014;7 (2):188–99.Google ScholarPubMed
Radford, D, Walters, DL. Balloon aortic valvotomy in pregnancy. Aust N Z J Obstet Gynaecol 2004;44:577–9.CrossRefGoogle ScholarPubMed
Gopal, K, Hudson, IM, Ludmir, J, et al. Homograft aortic root replacement during pregnancy. Ann Thorac Surg 2002;74:243–5.CrossRefGoogle ScholarPubMed
Parry, AJ, Westaby, S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996;61:1865–9.CrossRefGoogle ScholarPubMed
Chambers, CE, Clark, SL. Cardiac surgery during pregnancy. Clin Obstet Gynecol 1994;37:316–23.CrossRefGoogle ScholarPubMed
Jahangiri, M, Clarke, J, Prefumo, F, et al. Cardiac surgery during pregnancy: Pulsatile or non-pulsatile perfusion? J Thorac Cardiovasc Surg 2003;126:894–5.CrossRefGoogle ScholarPubMed
Ioscovich, AM, Goldszmidt, E, Fadeev, AV, et al. Peripartum anesthetic management of patients with aortic valve stenosis: A retrospective study and literature review. Int J Obstst Anesth 2009;18:379–86.Google ScholarPubMed
Suntharalingam, G, Dob, D, Yentis, SM. Obstetric epidural analgesia in aortic stenosis: A low-dose technique for labour and instrumental delivery. Int J Obstet Anesth 2001;10:129–34.CrossRefGoogle ScholarPubMed

References

Nieminen, HP, Jokinen, EV, Sairanen, HI. Late results of pediatric cardiac surgery in Finland: A population-based study with 96% follow-up. Circulation 2001;104:570–5.CrossRefGoogle ScholarPubMed
Thorne, S, Deanfield, J. Long-term outlook in treated congenital heart disease. Arch Dis Child 1996;75:6–8.CrossRefGoogle ScholarPubMed
Wren, C, O’Sullivan, JJ. Survival with congenital heart disease and need for follow up in adult life. Heart 2001;85:438–43.CrossRefGoogle ScholarPubMed
Hoffman, JIE. Incidence, mortality, and natural history. In: Anderson, RA et al., eds. Paediatric Cardiology. London: Churchill Livingstone; 2002. pp. 111–139.Google Scholar
Uebing, A, Steer, PJ, Yentis, SM, et al. Pregnancy and congenital heart disease. BMJ 2006;332:401–6.CrossRefGoogle ScholarPubMed
Warnes, CA, Williams, RG, Bashore, TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e714–833.CrossRefGoogle Scholar
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Siu, SC, Sermer, M, Colman, JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515–21.CrossRefGoogle ScholarPubMed
Siu, SC, Sermer, M, Harrison, DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789–94.Google ScholarPubMed
Franklin, WJ, Gandhi, M. Congenital heart disease in pregnancy. Cardiol Clin 2012;30:383–94.CrossRefGoogle ScholarPubMed
Steer, PJ. Pregnancy and contraception. In: Gatzoulis, MA, et al., eds. Adult Congenital Heart Disease: A Practical Guide. Malden, MA: BMJ Publishing Group; 2005. pp. 16–35.Google Scholar
Baddour, LM, Wilson, WR, Bayer, AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394–434.CrossRefGoogle Scholar
Feldt, RH, Avasthey, P, Yoshimasu, F, et al. Incidence of congenital heart disease in children born to residents of Olmsted County, Minnesota, 1950–1969. Mayo Clin Proc 1971;46:794–9.Google Scholar
Brochu, M-C, Baril, J-F, Dore, A, et al. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 2002;106:1821–6.CrossRefGoogle ScholarPubMed
Attie, F, Rosas, M, Granados, N, et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol 2001;38:2035–42.CrossRefGoogle Scholar
Gatzoulis, MA, Freeman, MA, Siu, SC, et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839–46.CrossRefGoogle ScholarPubMed
Murphy, JG, Gersh, BJ, McGoon, MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990;323:1645–50.CrossRefGoogle ScholarPubMed
Yap, S-C, Drenthen, W, Meijboom, FJ, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG 2009;116:1593–601.CrossRefGoogle ScholarPubMed
Giglia, TM, Massicotte, MP, Tweddell, JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: A scientific statement from the American Heart Association. Circulation 2013;128:2622–703.CrossRefGoogle ScholarPubMed
Babu-Narayan, S, Gatzoulis, MA. Tetralogy of Fallot. In: Gatzoulis, M, Wegg, GD, Daubeney, PEF, eds. Diagnosis and management of adult congenital heart disease, 2nd edn. Philadelphia, PA: Elsevier Saunders; 2011. pp. 316–27.Google ScholarPubMed
Hoffman, JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995;16:103–13.CrossRefGoogle ScholarPubMed
Gatzoulis, MA, Balaji, S, Webber, SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 2000;356:975–81.CrossRefGoogle ScholarPubMed
Khairy, P, Ouyang, DW, Fernandes, SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517–24.CrossRefGoogle ScholarPubMed
Greutmann, M, Von Klemperer, K, Brooks, R, et al. Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J 2010;31:1764–70.CrossRefGoogle ScholarPubMed
Veldtman, GR, Connolly, HM, Grogan, M, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004;44:174–80.CrossRefGoogle ScholarPubMed
Meijer, JM, Pieper, PG, Drenthen, W, et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 2005;91:801–5.CrossRefGoogle ScholarPubMed
Balci, A, Drenthen, W, Mulder, BJM, et al. Pregnancy in women with corrected tetralogy of Fallot: Occurrence and predictors of adverse events. Am Heart J 2011;161:307–13.CrossRefGoogle ScholarPubMed
Kamiya, CA, Iwamiya, T, Neki, R, et al. Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of fallot. Circ J 2012;76:957–63.CrossRefGoogle ScholarPubMed
Uebing, A, Arvanitis, P, Li, W, et al. Effect of pregnancy on clinical status and ventricular function in women with heart disease. Int J Cardiol 2010;139:50–9.CrossRefGoogle ScholarPubMed
Nora, JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994;23:1468–71.CrossRefGoogle ScholarPubMed
Gelson, E, Gatzoulis, M, Steer, PJ, et al. Tetralogy of Fallot: Maternal and neonatal outcomes. BJOG 2008;115:398–402.CrossRefGoogle ScholarPubMed
Connolly, HM, Warnes, CA. Ebstein’s anomaly: Outcome of pregnancy. J Am Coll Cardiol 1994;23:1194–8.CrossRefGoogle ScholarPubMed
Katsuragi, S, Kamiya, C, Yamanaka, K, et al. Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol 2013;209:452.e1–6.CrossRefGoogle ScholarPubMed
Brickner, ME, Hillis, LD, Lange, RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000;342:256–63.CrossRefGoogle ScholarPubMed
Elkayam, U, Bitar, F. Valvular heart disease and pregnancy part I: Native valves. J Am Coll Cardiol 2005;46:223–30.CrossRefGoogle ScholarPubMed
Loya, YS, Desai, DM, Sharma, S. Mitral and pulmonary balloon valvotomy in pregnant patients. Indian Heart J 1993;45:57–9.Google ScholarPubMed
Connolly, HM, Grogan, M, Warnes, CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 1999;33:1692–5.CrossRefGoogle ScholarPubMed
Therrien, J, Barnes, I, Somerville, J. Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol 1999;84:820–4.CrossRefGoogle ScholarPubMed
Bowater, SE, Selman, TJ, Hudsmith, LE, et al. Long-term outcome following pregnancy in women with a systemic right ventricle: Is the deterioration due to pregnancy or a consequence of time? Congenit Heart Dis 2013;8:302–7.CrossRefGoogle ScholarPubMed
Kowalik, E, Klisiewicz, A, Biernacka, EK, et al. Pregnancy and long-term cardiovascular outcomes in women with congenitally corrected transposition of the great arteries. Int J Gynaecol Obstet 2014;125:154–7.CrossRefGoogle ScholarPubMed
Dob, DP, Naguib, MA, Gatzoulis, MA. A functional understanding of moderate to complex congenital heart disease and the impact of pregnancy. Part I: The transposition complexes. Int J Obstet Anesth 2010;19:298–305.CrossRefGoogle ScholarPubMed
Clarkson, PM, Wilson, NJ, Neutze, JM, et al. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994;24:190–3.CrossRefGoogle ScholarPubMed
Drenthen, W, Pieper, PG, Roos-Hesselink, JW, et al. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol 2007;49:2303–11.CrossRefGoogle ScholarPubMed
Guédès, A, Mercier, L-A, Leduc, L, et al. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 2004;44:433–7.CrossRefGoogle ScholarPubMed
Canobbio, MM, Mair, DD, van der Velde, M, et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996;28:763–7.CrossRefGoogle ScholarPubMed
Ono, M, Boethig, D, Goerler, H, et al. Clinical outcome of patients 20 years after Fontan operation–effect of fenestration on late morbidity. Eur J Cardiothorac Surg 2006;30:923–9. doi:10.1016/j.ejcts.2006.08.025.CrossRefGoogle ScholarPubMed
D’ Udekem, Y, Iyengar, AJ, Cochrane, AD, et al. The Fontan procedure: Contemporary techniques have improved long-term outcomes. Circulation 2007;116:I157–64.CrossRefGoogle Scholar
Nitsche, JF, Phillips, SD, Rose, CH, et al. Pregnancy and delivery in patients with fontan circulation: A case report and review of obstetric management. Obstet Gynecol Surv 2009;64:607–14.CrossRefGoogle ScholarPubMed
Neumayer, U, Somerville, J. Outcome of pregnancies in patients with complex pulmonary atresia. Heart 1997;78:16–21.CrossRefGoogle ScholarPubMed
Presbitero, P, Somerville, J, Stone, S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673–6.CrossRefGoogle ScholarPubMed
Gatzoulis, MA, Swan, L, Therrien, J, et al. Adult Congenital Heart Disease: A Practical Guide. Oxford: BMJ Publishing Group, 2005.CrossRefGoogle Scholar
Uebing, A, John, A, Gatzoulis, M. Adult congenital heart disease. In: Myerson, SG, et al. Emergencies in Cardiology. New York: Oxford University Press; 2009. pp. 217–46.Google Scholar

References

Simonneau, G, Gatzoulis, MA, Adatia, I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–41.CrossRefGoogle ScholarPubMed
Kiely, DG, Elliot, CA, Sabroe, I, Condliffe, R. Pulmonary hypertension: Diagnosis and management. BMJ. 2013;346:f2028.CrossRefGoogle ScholarPubMed
Condliffe, R, Kiely, DG, Gibbs, JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122–7.CrossRefGoogle ScholarPubMed
Humbert, M, Sitbon, O, Simonneau, G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425–36.CrossRefGoogle ScholarPubMed
Humbert, M, Morrell, NW, Archer, SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S–24S.CrossRefGoogle ScholarPubMed
Moser, KM, Bloor, CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685–92.CrossRefGoogle ScholarPubMed
Montani, D, Achouh, L, Dorfmuller, P, et al. Pulmonary veno-occlusive disease: Clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87:220–33.CrossRefGoogle Scholar
Rich, S, Dantzker, DR, Ayres, SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216–23.CrossRefGoogle ScholarPubMed
Swift, AJ, Rajaram, S, Condliffe, R, et al. CT features of pulmonary arterial hypertension and its major subtypes: A systematic CT evaluation of 292 patients from the ASPIRE registry. Thorax. 2015;70:382–7.Google Scholar
Swift, AJ, Rajaram, S, Condliffe, R, et al. Normalised cardiovascular magnetic resonance volumetric measurements have prognostic value in idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2013;10:1036–47.Google Scholar
Swift, AJ, Rajaram, S, Condliffe, R, et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson. 2012;14:40.CrossRefGoogle ScholarPubMed
Swift, AJ, Wild, JM, Nagle, SK, et al. Quantitative magnetic resonance imaging of pulmonary hypertension: A practical approach to the current state of the art. J Thorac Imaging. 2014;29:68–79.CrossRefGoogle ScholarPubMed
Ling, Y, Johnson, MK, Kiely, DG, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186:790–6.CrossRefGoogle ScholarPubMed
Stupi, AM, Steen, VD, Owens, GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986;29:515–24.CrossRefGoogle ScholarPubMed
Rubin, LJ, Mendoza, J, Hood, M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med. 1990;112:485–91.CrossRefGoogle ScholarPubMed
Rubin, LJ, Badesch, DB, Barst, RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346:896–903.CrossRefGoogle ScholarPubMed
Pulido, T, Adzerikho, I, Channick, RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369:809–18.CrossRefGoogle ScholarPubMed
Galie, N, Olschewski, H, Oudiz, RJ, et al. Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation. 2008;117:3010–19.CrossRefGoogle ScholarPubMed
Galie, N, Ghofrani, HA, Torbicki, A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–57.CrossRefGoogle ScholarPubMed
Galie, N, Brundage, BH, Ghofrani, HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119:2894–903.CrossRefGoogle ScholarPubMed
Ghofrani, HA, Galie, N, Grimminger, F, et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013;369:330–40.Google ScholarPubMed
Olschewski, H, Simonneau, G, Galie, N, et al. Aerosolized Iloprost Randomized Study G. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322–9.CrossRefGoogle Scholar
Simonneau, G, Barst, RJ, Galie, N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800–4.CrossRefGoogle ScholarPubMed
Higenbottam, TW, Butt, AY, Dinh-Xaun, AT, et al. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart. 1998;79:175–9.CrossRefGoogle ScholarPubMed
Benza, RL, Tapson, VF, Gomberg-Maitland, M, et al. One-year experience with intravenous treprostinil for pulmonary arterial hypertension. J Heart Lung Transplant. 2013;32:889–96.CrossRefGoogle ScholarPubMed
Weiss, BM, Zemp, L, Seifert, B, et al. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650–7.CrossRefGoogle ScholarPubMed
Weiss, BM, Hess, OM. Pulmonary vascular disease and pregnancy: Current controversies, management strategies, and perspectives. Eur Heart J. 2000;21:104–15.CrossRefGoogle Scholar
Poppas, A, Shroff, SG, Korcarz, CE, et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 1997;95:2407–15.CrossRefGoogle ScholarPubMed
Hunter, S, Robson, SC. Adaptation of the maternal heart in pregnancy. British Heart Journal. 1992;68:540–3.CrossRefGoogle ScholarPubMed
Cheek, TG, Gruttsche, BB. Maternal physiologic alteration during pregnancy. In: Shnider and Levinson’s Anesthesia for Obstetrics. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 3–18.Google Scholar
Bonnin, M, Mercier, FJ, Sitbon, O, et al. Severe pulmonary hypertension during pregnancy: Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005;102:1133–7; discussion 1135A–1136A.CrossRefGoogle ScholarPubMed
Easterling, TR, Ralph, DD, Schmucker, BC. Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators. Obstet Gynecol. 1999;93:494–8.Google ScholarPubMed
Gleicher, N, Midwall, J, Hochberger, D, Jaffin, H. Eisenmenger’s syndrome and pregnancy. Obstet Gynecol Surv. 1979;34:721–41.CrossRefGoogle Scholar
Avila, WS, Grinberg, M, Snitcowsky, R, et al. Maternal and fetal outcome in pregnant women with Eisenmenger’s syndrome. Eur Heart J. 1995;16:460–4.CrossRefGoogle ScholarPubMed
Presbitero, P, Rabajoli, F, Somerville, J. Pregnancy in patients with congenital heart disease. Schweiz Med Wochenschr. 1995;125:311–15.Google ScholarPubMed
Presbitero, P, Somerville, J, Stone, S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89:2673–6.CrossRefGoogle ScholarPubMed
Saha, A, Balakrishnan, KG, Jaiswal, PK, et al. Prognosis for patients with Eisenmenger syndrome of various etiology. Int J Cardiol. 1994;45:199–207.CrossRefGoogle Scholar
Smedstad, KG, Cramb, R, Morison, DH. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth. 1994;41:502–12.CrossRefGoogle ScholarPubMed
Bedard, E, Dimopoulos, K, Gatzoulis, MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30:256–65.Google ScholarPubMed
Elliot, CA, Stewart, P, Webster, VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J. 2005;26:168–73.CrossRefGoogle Scholar
Monnery, L, Nanson, J, Charlton, G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth. 2001;87:295–8.CrossRefGoogle ScholarPubMed
Bendayan, D, Hod, M, Oron, G, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005;106:1206–10.CrossRefGoogle ScholarPubMed
Ma, L, Liu, W, Huang, Y. Perioperative management for parturients with pulmonary hypertension: Experience with 30 consecutive cases. Frontiers of Medicine. 2012;6:307–10.CrossRefGoogle ScholarPubMed
Duarte, AG, Thomas, S, Safdar, Z, et al. Management of pulmonary arterial hypertension during pregnancy: A retrospective, multicenter experience. Chest. 2013;143:1330–6.CrossRefGoogle ScholarPubMed
Cotrim, SC, Loureiro, MJ, Avillez, T, et al. Three cases of pregnancy in patients with severe pulmonary arterial hypertension: Experience of a single unit. Rev Port Cardiol. 2010;29:95–103.Google ScholarPubMed
Kiely, DG, Condliffe, R, Webster, V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG. 2010;117:565–74.CrossRefGoogle ScholarPubMed
Rosengarten, D, Blieden, LC, Kramer, MR. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012;40:1304–5.CrossRefGoogle Scholar
Curry, RA, Fletcher, C, Gelson, E, et al. Pulmonary hypertension and pregnancy–a review of 12 pregnancies in nine women. BJOG. 2012;119:752–61.CrossRefGoogle ScholarPubMed
Jais, X, Olsson, KM, Barbera, JA, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012;40:881–5.CrossRefGoogle ScholarPubMed
Kiely, DG, Condliffe, R, Wilson, V, et al. Pregnancy and pulmonary hypertension: A practical approach to management. Obstetric Medicine. 2013;6:144–54.CrossRefGoogle Scholar
Actelion Pharmaceuticals (Data on file). 3rd Trax PMS Data Report to CPMP for the period 24 May to 19 February 2003. 2003.
Billings, C, Waterhouse, J, Armstrong, IJ, et al. The incremental shuttle walking test safely assesses exercise capacity in pulmonary hypertension. Eur Respir J. 2004;24:S(137).Google Scholar
Elliot, CA, Armstrong, IJ, Billings, C, et al. Incremental shuttle walking test distance predicts poor prognosis in pulmonary hypertension. Eur Respir J. 2004;24:S138.Google Scholar
Huddy, CL, Johnson, A, Hope, PL. Educational and behavioural problems in babies of 32–35 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;85:F23–8.CrossRefGoogle ScholarPubMed
Jonas, MM, Tanser, SJ. Lithium dilution measurement of cardiac output and arterial pulse waveform analysis: An indicator dilution calibrated beat-by-beat system for continuous estimation of cardiac output. Curr Opin Crit Care. 2002;8:257–61.CrossRefGoogle ScholarPubMed
Hema, KR, Johanson, R. Techniques for performing caesarean section. Best Pract Res Clin Obstet Gynaecol. 2001;15:17–47.CrossRefGoogle ScholarPubMed
Pinder, AJ, Dresner, M, Calow, C, et al.. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth. 2002;11:156–9.CrossRefGoogle ScholarPubMed
Badalian, SS, Silverman, RK, Aubry, RH, et al. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med. 2000;45:149–52.Google Scholar
Wong, PS, Constantinides, S, Kanellopoulos, V, et al. Primary pulmonary hypertension in pregnancy. J R Soc Med. 2001;94:523–5.Google ScholarPubMed
Ghai, B, Mohan, V, Khetarpal, M, et al. Epidural anesthesia for cesarean section in a patient with Eisenmenger’s syndrome. Int J Obstet Anesth. 2002;11:44–7.CrossRefGoogle Scholar
O’Hare, R, McLoughlin, C, Milligan, K, et al. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth. 1998;81:790–2.Google ScholarPubMed
Weeks, SK, Smith, JB. Obstetric anaesthesia in patients with primary pulmonary hypertension. Can J Anaesth. 1991;38:814–16.CrossRefGoogle ScholarPubMed
Blaise, G, Langleben, D, Hubert, B. Pulmonary arterial hypertension: Pathophysiology and anesthetic approach. Anesthesiology. 2003;99:1415–32.CrossRefGoogle ScholarPubMed

References

Elliott, P, Andersson, B, Arbustini, E et al. Classification of the cardiomyopathies: A position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29:270–6.Google Scholar
Van Tintelen, JP, Pieper, PG, Van Spaendonck-Zwarts, KY, et al. Pregnancy, cardiomyopathies and genetics. Cardiovasc Res 2014;101:571–8.CrossRefGoogle ScholarPubMed
Anderson, JL, Horne, BD. Birthing the genetics of peripartum cardiomyopathy. Circulation 2010;121:2157–9.CrossRefGoogle ScholarPubMed
Rapezzi, C, Arbustini, E, Caforio, A et al. Diagnostic work up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:1448–58.CrossRefGoogle Scholar
Blauwet, L, Sliwa, K. Peripartum cardiomyopathy. Obstet Med 2011;4:44–52.CrossRefGoogle ScholarPubMed
Grewal, J, Siu, SC, Ross, HJ, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2010;55:45–52.CrossRefGoogle ScholarPubMed
Blatt, A, Svirski, R, Morawsky, G, et al. Short and long-term outcome of pregnant women with pre-existing dilated cardiomyopathy: An NTproBNP and echocardiography-guided study. IMAJ 2010;12:613–16.Google Scholar
Palojoki, E, Kaartinen, M, Kaaja, R, et al. Pregnancy and childbirth in carriers of the lamin A/C gene mutation. European Journal of Heart Failure 2010;12:630–3.CrossRefGoogle ScholarPubMed
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Sliwa, K, Hilfiker-Kleiner, D, Petrie, MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78.CrossRefGoogle Scholar
Pearson, GD, Veille, JC, Rahimtoola, S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.CrossRefGoogle ScholarPubMed
Hibbard, JU, Lindheimer, M, Lang, RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Am J Obstet Gynecol 1999;94:311–16.Google ScholarPubMed
Elkayam, U, Akhter, MW, Singh, H, et al. Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050–5.CrossRefGoogle Scholar
Bachelier-Walenta, K, Hilfiker-Kleiner, D, Sliwa, K. Acute heart failure: Is it peripartum cardiomyopathy or not? Obstet Med 2013;6:42–4.CrossRefGoogle ScholarPubMed
Fett, JD, Christie, LG, Carraway, RD, et al. Unrecognized peripartum cardiomyopathy in Haitian women. Int J Gynaecol Obstet. 2005;90(2):161–6.CrossRefGoogle ScholarPubMed
Lim, CP, Sim, DK. Peripartum cardiomyopathy: Experience in an Asian tertiary centre. Singapore Med J. 2013;54(1):24–7.Google Scholar
Kolte, D, Khera, S, Aronow, WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: A nationwide population-based study. J Am Heart Assoc. 2014;4;3(3):e001056.CrossRefGoogle ScholarPubMed
Hilfiker-Kleiner, D, Sliwa, K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11(6):364–70.CrossRefGoogle ScholarPubMed
Sliwa, K, Hilfiker-Kleiner, D, Mebazaa, A, et al. EURObservational Research Programme: A worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail. 2014;16(5):583–91.CrossRefGoogle Scholar
Kao, DP, Hsich, E, Lindenfeld, J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail. 2013;1(5):409–16.CrossRefGoogle ScholarPubMed
Shani, H, Kuperstein, R, Berlin, A, et al. Peripartum cardiomyopathy—risk factors, characteristics and long-term follow-up. J Perinat Med. 2015;43(1):95–101.Google ScholarPubMed
Prasad, GS, Bhupali, A, Prasad, S, Patil, AN, Deka, Y. Peripartum cardiomyopathy—case series. Indian Heart J. 2014 Mar-Apr;66(2):223–6.CrossRefGoogle ScholarPubMed
Morales, A, Painter, T, Li, R, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010;121:2176–82.CrossRefGoogle ScholarPubMed
Van Spaendonck-Zwarts, KY, van Tintelen, JP, van Veldhuisen, DJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169–75.CrossRefGoogle ScholarPubMed
Van Spaendonck-Zwarts, KY, Posafalvi, A, van den Berg, MP, et al. Titn gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014;35(32):2165–73.CrossRefGoogle Scholar
Midei, MG, DeMent, SH, Feldman, AM, Hutchins, GM, Baughman, KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922–8.CrossRefGoogle ScholarPubMed
Felker, GM, Thompson, RE, Hare, JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077–84.CrossRefGoogle ScholarPubMed
Bultmann, BD, Klingel, K, Nabauer, M, Wallwiener, D, Kandolf, R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363–5.CrossRefGoogle ScholarPubMed
Sliwa, K, Forster, O, Libhaber, E, et al. Peripartum cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27:441–6.Google ScholarPubMed
Huang, GY, Zhang, LY, Long-Le, MA, Wang, LX. Clinical characteristics and risk factors for peripartum cardiomyopathy. Afr Health Sci. 2012 Mar;12(1):26–31.Google ScholarPubMed
Warraich, RS, Sliwa, K, Damasceno, A, et al. Impact of pregnancy-related heart failure on humoral immunity: Clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 2005;150:263–9.CrossRefGoogle ScholarPubMed
Hilfiker-Kleiner, D, Sliwa, K. Pathophysiology and epidemiology of peripartum cardiomyopathy.Nat Rev Cardiol 2014 Jun;11(6):364–70.CrossRefGoogle ScholarPubMed
Hilfiker-Kleiner, D, Kaminski, K, Podewski, E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128(3):589–600.CrossRefGoogle ScholarPubMed
Sliwa, K, Blauwet, L, Tibazarwa, K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study. Circulation. 2010 Apr 6;121(13):1465–73.CrossRefGoogle ScholarPubMed
Elkayam, U. Clinical characteristics of peripartum cardiomyopathy in the United States: Diagnosis, prognosis, and management. J Am Coll Cardiol. 2011 Aug 9;58(7):659–70.CrossRefGoogle ScholarPubMed
Royal College of Obstetricians and Gynaecologists. RCOG Green Top Guideline. No. 37a. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. 2015. [https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf] Accessed August 7, 2015.
Mohan, A, Nelson-Piercy, C. Drugs and therapeutics, including contraception, for women with heart disease. In: Walker, F, O’Brien, P, eds. Heart Disease in Pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014;28(4):471–82.Google Scholar
Safirstein, JG1, Ro, AS, Grandhi, S, et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31.CrossRefGoogle Scholar
Witlin, AG, Mabie, WC, Sibai, BM. Peripartum cardiomyopathy: A longitudinal echocardiographic study. Am J Obstet Gynecol 1997;177:1129–32.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence. NICE Guideline GC108. Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. 2010. [http://www.nice.org.uk/guidance/cg108] Accessed August 10, 2015.
Mouquet, F, Mostefa Kara, M, Lamblin, N, et al. Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: Impact of cardiac resynchronization therapy. Eur J Heart Fail 2012;14(5):526–9.CrossRefGoogle Scholar
National Institute for Health and Care Excellence. NICE Technology Appraisal TA 314. Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120). 2014. [https://www.nice.org.uk/guidance/ta314] Accessed August 10, 2015.
Cantwell, R, Clutton-Brock, T, Cooper, G. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the UK. BJOG, 118 (Suppl 1):1–203.
Murali, S, Baldisseri, MR. Peripartum cardiomyopathy. Crit Care Med 2005;33(10 Suppl):S340–6.CrossRefGoogle ScholarPubMed
Blauwet, LA, Libhaber, E, Forster, O, et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart. 2013 Mar;99(5):308–13.CrossRefGoogle ScholarPubMed
Pillarisetti, J, Kondur, A, Alani, A, et al. Peripartum cardiomyopathy: Predictors of recovery and current state of implantable cardioverter-defibrillator use. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2831–9.CrossRefGoogle ScholarPubMed
Cooper, LT, Mather, PJ, Alexis, JD, et al. Myocardial recovery in peripartum cardiomyopathy: Prospective comparison with recent onset cardiomyopathy in men and non-peripartum women. J Card Fail. 2012;18:28–33.CrossRefGoogle Scholar
Lampert, MB, Weinert, L, Hibbard, J, et al. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Obstet Gynecol 1997;176:189–95.Google ScholarPubMed
Elkayam, U. Pregnant again after peripartum cardiomyopathy: To be or not to be? Eur Heart J 2002;23:753–6.CrossRefGoogle ScholarPubMed
Witlin, AG, Mabie, WC, Sibai, BH. Peripartum cardiomyopathy: An ominous diagnosis. Am J Obstet Gynecol 1997;176:182–8.CrossRefGoogle Scholar
Dorbala, S, Brozena, S, Zeb, S, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: A dobutamine stress echocardiography study. J Am Soc Echocardiogr 2005;18:45–8.CrossRefGoogle Scholar
Goland, S, Bitar, F, Modi, K et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Cardiac Fail. 2011;17:426–30.CrossRefGoogle ScholarPubMed
Bernstein, PS, Magriples, U. Cardiomyopathy in pregnancy: A retrospective study. Am J Perinatol 2001;18:163–8.CrossRefGoogle ScholarPubMed
Katsuragi, S, Omoto, A, Kamiya, C, et al. Risk factors for maternal outcome in pregnancy complicated with dilated cardiomyopathy. J Perinatol 2012;32:170–5.CrossRefGoogle ScholarPubMed
Suri, V, Aggarwal, N, Kalpdev, A, et al. Pregnancy with dilated and peripartum cardiomyopathy: Maternal and fetal outcome. Arch Gynecol Obstet 2013;287:195–9.CrossRefGoogle ScholarPubMed
Saltzberg, MT, Szymkiewicz, S, Bianco, NR. Characteristics and outcomes of peripartum vs non peripartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 2012;18:21–7.CrossRefGoogle Scholar
Demakis, JG, Rahimtoola, SH, Sutton, GC, et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053–61.Google ScholarPubMed
Elkayam, U, Tummala, PP, Rao, K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344 :1567–71.CrossRefGoogle Scholar
Fett, JD, Fristoe, KL, Welsh, SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet 2010;109:34–6.CrossRefGoogle ScholarPubMed
Avila, WS, de Carvalho, ME, Tschaen, CK, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol 2002;79:484–93.CrossRefGoogle ScholarPubMed
Mishra, TK, Swain, S, Routray, SN. Peripartum cardiomyopathy. Int J Gynecol Obstet 2006;95:104–9.CrossRefGoogle ScholarPubMed
Habli, M, O’Brien, T, Nowack, E, et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008;199:415,e1–5.CrossRefGoogle ScholarPubMed
Modi, KA, Illum, S, Jariatul, K, Caldito, G, Reddy, PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol 2009;201: 171.e1–5.CrossRefGoogle ScholarPubMed
Elliott, P, McKenna, WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881–91.CrossRefGoogle ScholarPubMed
Schinkel, AF. Pregnancy in women with hypertrophic cardiomyopathy. Cardiol Rev 2014;22:217–22.CrossRefGoogle ScholarPubMed
Thaman, R, Varnava, A, Hamid, MS, et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003;89:752–6.CrossRefGoogle ScholarPubMed
Autore, C, Conte, MR, Piccininno, M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1864–9.CrossRefGoogle ScholarPubMed
Probst, V, Langlard, JM, Desnos, M, et al. Familial hypertrophic cardiomyopathy. French study of the duration and outcome of pregnancy. Arch Mal Coeur Vaiss 2002;95:81–6.Google ScholarPubMed
Tanaka, H, Kamiya, C, Katsuragi, S, et al. Cardiovascular events in pregnancy with hypertrophic cardiomyopathy. Circ J. 2014;78:2501–6.CrossRefGoogle ScholarPubMed
Mogensen, J, Arbustini, E. Restrictive cardiomyopathy. Curr Opin Cardiol. 2009;24:214–20.CrossRefGoogle ScholarPubMed
Smith, W, Members of CSANZ Cardiovascular Genetics Working Group. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Heart Lung Circ. 2011;20:757–60.CrossRefGoogle Scholar
Bauce, B, Daliento, L, Frigo, G, et al. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006;127:186–9.CrossRefGoogle ScholarPubMed
Iriyama, T, Kamei, Y, Kozuma, S, et al. Management of patient with arrhythmogenic right ventricular cardiomyopathy during pregnancy. J Obstet Gynaecol Res 2013;39:390–4.CrossRefGoogle ScholarPubMed
Lee, LC, Bathgate, SL, Macri, CJ. Arrhythmogenic right ventricular dysplasia in pregnancy: A case report. J Reprod Med 2006;51:725–8.Google ScholarPubMed
Murray, B, Tichnell, C, James, C, Tandri, H, Calkins, H. Pregnancy in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2013;62:1910–11.CrossRefGoogle ScholarPubMed
Cozzolino, M, Perelli, F, Corioni, S, Carpinella, G, Mecacci, F. Successful obstetric management of arrhythmogenic right ventricular cardiomyopathy. Gynecol Obstet Invest 2014;78:266–71.CrossRefGoogle ScholarPubMed
Doyle, NM, Monga, M, Montgomery, B, et al. Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy. J Matern Fetal Neonatal Med 2005;18:141–4.CrossRefGoogle ScholarPubMed
Stec, S, Krynski, T, Baran, J, Kulakowski, P. “Rescue” ablation of electrical storm in arrhythmogenic right ventricular cardiomyopathy in pregnancy. BMC Cardiovasc Disord 2013;13:58.CrossRefGoogle ScholarPubMed

References

Croft, P, Hannaford, PC. Risk factors for acute myocardial infarction in women: Evidence from the Royal College of General Practitioners’ oral contraception study. BMJ. 1989;298(6667):165–8.Google ScholarPubMed
James, AH, Jamison, MG, Biswas, MS, et al. Acute myocardial infarction in pregnancy: A United States population-based study. Circulation. 2006;113(12):1564–71.CrossRefGoogle ScholarPubMed
Roth, A, Elkayam, U. Acute myocardial infarction associated with pregnancy. Ann Intern Med. 1996;125(9):751–62.CrossRefGoogle ScholarPubMed
Elkayam, U, Jalnapurkar, S, Barakkat, MN, et al. Pregnancy-associated acute myocardial infarction: A review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014;129(16):1695–702.CrossRefGoogle Scholar
Hunter, S, Robson, SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68(6):540–3.CrossRefGoogle ScholarPubMed
Roth, A, Elkayam, U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol. 2008;52(3):171–80.CrossRefGoogle ScholarPubMed
Ascarelli, MH, Grider, AR, Hsu, HW. Acute myocardial infarction during pregnancy managed with immediate percutaneous transluminal coronary angioplasty. Obstet Gynecol. 1996;88(4 Pt 2):655–7.CrossRefGoogle ScholarPubMed
Badui, E, Enciso, R. Acute myocardial infarction during pregnancy and puerperium: A review. Angiology. 1996;47(8):739–56.CrossRefGoogle ScholarPubMed
Lewis, G. (Ed). Saving Mothers’ Lives. Reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth Report of the Confidential Enquiry into Maternal Deaths BJOG. 2011 118 (11):1402–3; discussion 3–4.Google Scholar
Ray, P, Murphy, GJ, Shutt, LE. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93(3):428–39.CrossRefGoogle ScholarPubMed
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Teunen, D. The European Directive on health protection of individuals against the dangers of ionising radiation in relation to medical exposures (97/43/EURATOM). J Radiol Prot. 1998;18(2):133–7.CrossRefGoogle Scholar
Colletti, PM, Lee, KH, Elkayam, U. Cardiovascular imaging of the pregnant patient. AJR Am J Roentgenol. 2013;200(3):515–21.CrossRefGoogle ScholarPubMed
Bates, SM, Greer, IA, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S-736S.CrossRefGoogle ScholarPubMed
U.S. Food and Drug Administration. Plavix Prescribing Information. www.accessdata.fda.gov/drugsatfda_docs/label/2013/020839s058lbl.pdf. Accessed September 9, 2014.[updated December 2013]
Heinonen, OP, Sloan, D, Shapiro, S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group; 1977.Google Scholar
Sheikh, AU, Harper, MA. Myocardial infarction during pregnancy: Management and outcome of two pregnancies. Am J Obstet Gynecol. 1993;169(2 Pt 1):279–83; discussion 83–4.CrossRefGoogle ScholarPubMed
Shalev, Y, Ben-Hur, H, Hagay, Z, et al. Successful delivery following myocardial ischemia during the second trimester of pregnancy. Clin Cardiol. 1993;16(10):754–6.CrossRefGoogle ScholarPubMed
Briggs, GG, Freeman, RK, Yaffe, SJ, eds. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore: Williams and Wilkins; 1994.Google Scholar
Stuart, MJ, Gross, SJ, Elrad, H, et al. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med. 1982;307(15):909–12.CrossRefGoogle ScholarPubMed
Zierler, S, Rothman, KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med. 1985;313(6):347–52.CrossRefGoogle ScholarPubMed
Viinikka, L, Hartikainen-Sorri, AL, Lumme, R, et al. Low dose aspirin in hypertensive pregnant women: Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol. 1993;100(9):809–15.CrossRefGoogle Scholar
CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994;343(8898):619–29.PubMed
Buttar, HS. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem. 1997;176(1–2):61–71.CrossRefGoogle ScholarPubMed
Hanssens, M, Keirse, MJ, Vankelecom, F, et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78(1):128–35.Google ScholarPubMed
Opasich, C, Russo, A, Colombo, E, et al. Your cardiac patient wants to become a mother. Risk considerations and advice. Part II–Your cardiac patient is pregnant. Ital Heart J. 2000;1(10):667–73.Google ScholarPubMed
Elkayam, U. Pregnancy and Cardiovascular Disease. In: Braunwald, E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 5th edn. Philadelphia: W.B. Saunders; 1997. pp. 1843–64.Google Scholar
U.S. Food and Drug Administration. Spironolactone Prescribing Information. www.accessdata.fda.gov/drugsatfda_docs/label/2008/012151s062lbl.pdf. Accessed September 9, 2014.[updated November 2008].
U.S. Food and Drug Administration. Simvastatin Prescribing Information. www.accessdata.fda.gov/drugsatfda_docs/label/2010/019766s078lbl.pdf. Accessed September 9, 2014.[updated March 2010].
Patel, A, Asopa, S, Tang, AT, et al. Cardiac surgery during pregnancy. Tex Heart Inst J. 2008;35(3):307–12.Google ScholarPubMed
Elassy, SM, Elmidany, AA, Elbawab, HY. Urgent cardiac surgery during pregnancy: A continuous challenge. Ann Thorac Surg. 2014;97(5):1624–9.CrossRefGoogle ScholarPubMed
Roos-Hesselink, JW, Ruys, TP, Stein, JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: Results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657–65.CrossRefGoogle ScholarPubMed
Gowda, RM, Khan, IA, Mehta, NJ, et al. Cardiac arrhythmias in pregnancy: Clinical and therapeutic considerations. Int J Cardiol. 2003;88(2–3):129–33.CrossRefGoogle ScholarPubMed

References

Niwa, K, Warita, N, Sunami